openPR Logo
Press release

The Photodynamic Therapy Market to Be Driven By Neurotechnology

02-16-2022 05:42 AM CET | Health & Medicine

Press release from: Persistence Market Research

The Photodynamic Therapy Market to Be Driven By Neurotechnology

The Photodynamic Therapy Market is expected to grow on a healthy note in the subsequent decade. With value-based care picking up, close to 15% of the entire population is under its umbrella as of now. Programs like "Online Bachelor's Degree in General Studies with a Concentration in Healthcare" is being floated, which could aid professionals to lead in the value-based care strategies. In other words, the future belongs to professionals bringing conventional skills in communication, care, and leadership with new-fangled skills in analytics and technology. So, "being value-based" would hold value in the healthcare vertical in the future.

Actinic keratosis, psoriasis, acne, rosacea, esophageal cancer, and basal cell carcinoma are considered to be the topmost risk factors that are boosting the demand for photodynamic therapy among the general population. However, the growing availability of FDA-approved photosensitizer drugs and laser systems is contributing to the increased adoption of novel and innovative technologies to treat various conditions of dermatology, ophthalmology, and oncology.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/25228

According to the Skin Cancer Foundation, one in five Americans are projected to develop skin cancer by the age of 70 years. Moreover, actinic keratosis has been registered as the most common precancer that affects over 58 million Americans. The above mentioned skin disorders, along with other indications, such as non-small cell lung cancer and esophageal cancer, can be treated effectively with the help of photosensitizer drugs. Thus, photodynamic therapy is the most preferred treatment among prevalent people for skin disorders and associated cancers, which is driving the demand for phototherapy devices and photosensitizer drugs, thus generating growth opportunities for the photodynamic therapy market.

Companies Profiles:

Galderma S.A.
Sun Pharmaceutical Industries Ltd.
Biofrontera
Novartis AG
Allergan Plc
Valeant Pharmaceuticals International, Inc.
Quest Pharmatech, Inc.
Hologic, Inc. (Cynosure Inc.)

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/25228

According to the latest research by PMR, the global photodynamic therapy market is estimated to have accounted for US$ 1,202.1 Mn in terms of value in 2019. The report on the photodynamic therapy market further projects that the photodynamic therapy market is likely to grow at a CAGR of 6.2% during the period 2019-2029.

The growing prevalence and incidence of skin cancers and dermatology disorders, mostly basal cell carcinoma, psoriasis, actinic keratosis, and rosacea, is boosting the demand for photodynamic therapy, and this is one of the leading factors contributing to the revenue growth of the photodynamic therapy market. Moreover, according to National Psoriasis Foundation, approximately 125 million people worldwide, which account for 2 to 3% of the total population, are known to suffer from psoriasis.

The synergy of photosensitizer drugs and devices represents a significant untapped potential for new entrants. Drug and device companies are collaborating to offer Photodynamic Therapy (PDT) devices, wherein drugs injected into the bodies of patients are later activated by light. Therefore, photodynamic therapy has become the most preferred treatment for skin cancer and ophthalmology conditions, which is a significant factor that is boosting its demand from end-use settings, thus driving the photodynamic therapy market.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/25228

Photodynamic therapy plays a vital role as the field of light therapy is emerging dramatically. Photodynamic therapy has substituted chemotherapy as well as radiation therapy. Moreover, photodynamic therapy has proven to be advantageous over chemotherapy as it can be repeated several times in one particular area.

Moreover, the introduction of technologically upgraded photodynamic therapy over conventional photodynamic therapy is further projected to boost the photodynamic therapy market. Photodynamic therapy being cheaper and minimally painful is advantageous for cancer patients as it enables them to avoid chemotherapy or surgery.

However, despite being the cost-effective treatment option for cancer, photodynamic therapy usage is restricted for patients who are sensitive to light or in case the cancer prevails in deeper body parts. Among photodynamic therapy devices, diode laser devices are high-cost medical devices, and this is hampering the demand for the same as compared to the demand for disposable fiber optic light delivery devices for the photodynamic therapy market.

The photosensitizer drugs segment is a leading revenue segment by product type in the photodynamic therapy market, and is expected to account for a revenue share of 78.3% in 2019. Among the photosensitizer drugs, Aminolevulinic Acid (ALA)-based drugs are the most widely preferred drugs as compared to Hematoporphyrin Derivative (HpD) and others. Among all the end users in the photodynamic therapy market, the hospitals segment is projected to remain a prominent segment over the forecast period, followed by the private dermatology clinics segment.

Complete Report Details@ https://www.persistencemarketresearch.com/market-research/photodynamic-therapy-market.asp

The photodynamic therapy market has been scrutinized across the regions of North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA. North America, followed by Europe, is a significant revenue-generating region in the global photodynamic therapy market. North America is expected to account for a revenue share of 34.5% in 2019 in the photodynamic therapy market.

Europe accounts for the second-highest revenue share in the global photodynamic therapy market with a substantial CAGR. It is followed by East Asia and Latin America in the photodynamic therapy market. Russia, China, and South Korea are emerging markets in the photodynamic therapy market. China is estimated to be one of the fastest-growing emerging markets in the global photodynamic therapy market, and is expected to grow at a CAGR of 5.7% over the forecast period of 2019-2029.

A majority of the regional players in the photodynamic therapy market are focused on increasing their product reach for drugs & devices and enhancing their connectivity with the regional distributors of photodynamic therapy products. The manufacturers of photodynamic therapy are focused on strengthening their businesses in opportunistic photodynamic therapy markets, such as Russia, China, India, South Korea, and Japan, by expanding their sales and distribution channels across these countries.

Related Reports:

Alopecia Treatment Market - https://www.persistencemarketresearch.com/market-research/alopecia-treatment-market.asp

Fibromyalgia Treatment Market - https://www.persistencemarketresearch.com/market-research/fibromyalgia-treatment-market.asp

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Photodynamic Therapy Market to Be Driven By Neurotechnology here

News-ID: 2553805 • Views:

More Releases from Persistence Market Research

Spectroscopy IR Detector Market Anticipated to Hit USD 1,370 Million by 2032
Spectroscopy IR Detector Market Anticipated to Hit USD 1,370 Million by 2032
Overview of the Spectroscopy IR Detector Market The global spectroscopy IR detector market has experienced steady growth in recent years, driven by technological advancements and increasing demand across various industries. Valued at US$ 211.0 million in 2024, the market is projected to reach US$ 825.8 million in 2025 and is anticipated to grow further to US$ 1,370 million by 2032, registering a robust CAGR of 7.5%. Rising environmental concerns and the
Spectrum Analyzer Market Anticipated to Hit USD 2,138.2 Million by 2032
Spectrum Analyzer Market Anticipated to Hit USD 2,138.2 Million by 2032
Overview of the Market The global spectrum analyzer market is poised for steady growth, with its valuation reaching US$ 1,762.4 million in 2025. Driven by increased adoption of wireless communication systems, rising demand for precise signal analysis, and rapid technological advancements in electronics testing, the market is expected to achieve US$ 2,138.2 million by 2032, registering a CAGR of 2.8% during the forecast period. Spectrum analyzers are crucial for testing, designing,
Speaker Driver Market Expected to Grow at a CAGR of 2.3% Through 2032
Speaker Driver Market Expected to Grow at a CAGR of 2.3% Through 2032
Overview of the Speaker Driver Market The global speaker driver market has witnessed steady growth in recent years, driven by surging demand for high-quality audio devices across consumer electronics, automotive, and professional audio segments. Valued at US$ 26.4 billion in 2024, the market is projected to reach US$ 26.8 billion by 2025 and expand to US$ 31.4 billion by 2032, registering a CAGR of 2.3% during the forecast period. The market
Signalling Devices Market Expected to Grow at a CAGR of 6.7% Through 2032
Signalling Devices Market Expected to Grow at a CAGR of 6.7% Through 2032
Overview of the Market The global signalling devices market is poised for steady growth, driven by rising demand across industrial, transportation, and residential sectors. Valued at US$ 2,181.20 million in 2024, the market is projected to reach US$ 3,643.90 million by 2032, reflecting a CAGR of 6.7% during the forecast period of 2025-2032. Increasing awareness about safety protocols and technological advancements in automation and IoT-enabled devices are major factors propelling market

All 5 Releases


More Releases for Photodynamic

Driving Photodynamic Therapy Market Growth in 2025: The Role of Rising Prevalenc …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Photodynamic Therapy Market Size Growth Forecast: What to Expect by 2025? Growth within the photodynamic therapy market size has seen a robust increase in recent years. The market size is predicted to rise from $1.45 billion in 2024 to $1.53 billion in 2025, demonstrating a compound annual growth rate
Photodynamic Therapy Market Competitive Analysis Forecast till 2030
According to Ameco Research 'Photodynamic Therapy Market report, the analysts took this into account when estimating the Photodynamic Therapy Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the Photodynamic Therapy Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes Photodynamic Therapy Market trends, segmentation, key
Photodynamic Therapy Market Report 2030
Photodynamic therapy market, a groundbreaking treatment, is reshaping the landscape of cancer therapy and dermatology. By harnessing the power of light and photosensitizing agents, PDT presents a promising solution in combating various cancers and skin conditions. With the global market projected to surge from USD 5 billion in 2021 to USD 18.1 billion by 2030, PDT is poised to revolutionize the medical sector. Download Sample Report Copy Of This Report From
Photodynamic Therapy Market | Share, Growth Report 2022 - 2030
The Photodynamic Therapy Market Research Report provides an in-depth analysis of the market dynamics, key players, and competitive landscape of the Photodynamic Therapy industry. It aims to provide valuable insights into the market trends, growth opportunities, and challenges faced by the industry stakeholders. The report serves as a comprehensive guide for businesses and investors looking to make informed decisions in the Photodynamic Therapy business. The Photodynamic Therapy Market share is influenced
Photodynamic Therapy Market - The future of targeted therapy: Empowering patient …
Newark, New Castle, USA: The "Photodynamic Therapy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Photodynamic Therapy Market: https://www.growthplusreports.com/report/photodynamic-therapy-market/7676 This latest report researches the industry structure, sales, revenue,
Photodynamic Therapy Market: Illuminating a Brighter Future in Cancer Treatment …
Actinic keratosis, psoriasis, acne, rosacea, esophageal cancer, and basal cell carcinoma are considered to be the topmost risk factors that are boosting the demand for photodynamic therapy among the general population. However, the growing availability of FDA-approved photosensitizer drugs and laser systems is contributing to the increased adoption of novel and innovative technologies to treat various conditions of dermatology, ophthalmology, and oncology. According to the Skin Cancer Foundation, one in five